Half-year report · Q2
3101.TEDINET S100UR21
Period2024-04-01 → 2024-09-30
Filed2024-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥209.2bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥414.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥199.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Operating income | ¥6.9bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Operating income | ¥2.4bn | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Ordinary income | ¥3.2bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥7.0bn | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥2.3bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥3.1bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥114m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.5bn | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.0bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥2.1bn | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Net income | ¥1.6bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Total assets | ¥603.2bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥607.0bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥577.2bn | at 2023-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥374.3bn | at 2024-09-30 | Cons. | Liabilities |
| Total liabilities | ¥376.9bn | at 2024-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥228.9bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥230.1bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥221.8bn | at 2023-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥28.4bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥33.8bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥27.1bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥33.3bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥29.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥60.2bn | at 2023-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥17.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥21.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥10.1bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥24.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥58.8bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥26.9bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.3bn | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥8.3bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥15.4bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥1.29 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.87 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.82 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 32.0% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.5% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 33.0% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 46
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥10.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥3.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥272m |
| Reconciling Itemsreconciling | revenue | 2024-04-01 → 2024-09-30 | −¥12.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-04-01 → 2024-09-30 | −¥12.7bn |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥1.6bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥17.3bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥17.2bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥53m |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥905m |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.1bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥581m |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥889m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥211.9bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥205.3bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥6.7bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥221.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥209.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥12.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥8.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥14.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥4.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥9.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥411m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥16.7bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥16.7bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥2.4bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥16.6bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥16.6bn |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥7m |
| jpcrp040300-q2r_E00525-000Life Sciencereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥2.4bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥2.6bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥2.0bn |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥582m |
| jpcrp040300-q2r_E00525-000Real Estatereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥971m |
| —segment total | revenue | 2023-04-01 → 2023-09-30 | ¥201.9bn |
| —segment total | revenue external | 2023-04-01 → 2023-09-30 | ¥194.8bn |
| —segment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥7.1bn |
| —segment total | segment profit | 2023-04-01 → 2023-09-30 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥216.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥199.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥16.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥4.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 515
| Item | Context | Value | Unit |
|---|---|---|---|
| Bonds payable | CurrentQuarterInstant | 67000000000 | JPY |
| Long term loans payable | Prior1YearInstant | 85637000000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 108192000000 | JPY |
| Deferred tax liabilities for land revaluation | Prior1YearInstant | 18762000000 | JPY |
| Deferred tax liabilities for land revaluation | CurrentQuarterInstant | 18754000000 | JPY |
| Provision for directors retirement benefits | Prior1YearInstant | 274000000 | JPY |
| Provision for directors retirement benefits | CurrentQuarterInstant | 177000000 | JPY |
| Provision for environmental measures ncl | Prior1YearInstant | 11000000 | JPY |
| Provision for environmental measures ncl | CurrentQuarterInstant | 11000000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 15901000000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 15322000000 | JPY |
| Other ncl | Prior1YearInstant | 12171000000 | JPY |
| Other ncl | CurrentQuarterInstant | 10888000000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 192755000000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 220344000000 | JPY |
| Liabilities | Prior1YearInstant | 376903000000 | JPY |
| Liabilities | CurrentQuarterInstant | 374307000000 | JPY |
| Capital stock | Prior1YearInstant | 51730000000 | JPY |
| Capital stock | CurrentQuarterInstant | 51730000000 | JPY |
| Capital surplus | Prior1YearInstant | 33187000000 | JPY |
| Capital surplus | CurrentQuarterInstant | 32647000000 | JPY |
| Retained earnings | Prior1YearInstant | 70315000000 | JPY |
| Retained earnings | CurrentQuarterInstant | 66954000000 | JPY |
| Treasury stock | Prior1YearInstant | -1006000000 | JPY |
| Treasury stock | CurrentQuarterInstant | -925000000 | JPY |
| Shareholders equity | Prior1YearInstant | 154227000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 150406000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 1801000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 1988000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | -1000000 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -74000000 | JPY |
| Revaluation reserve for land | Prior1YearInstant | 40603000000 | JPY |
| Revaluation reserve for land | CurrentQuarterInstant | 40590000000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | -548000000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | -785000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | 951000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | 1076000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 42806000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 42794000000 | JPY |
| Non controlling interests | Prior1YearInstant | 33054000000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 35669000000 | JPY |
| Net assets | Prior1YearInstant | 230087000000 | JPY |
| Net assets | CurrentQuarterInstant | 228869000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 606990000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 603176000000 | JPY |
| Net sales | Prior1YTDDuration | 199419000000 | JPY |
| Net sales | CurrentYTDDuration | 209161000000 | JPY |
| Cost of sales | Prior1YTDDuration | 157659000000 | JPY |
| Cost of sales | CurrentYTDDuration | 161892000000 | JPY |
| Gross profit | Prior1YTDDuration | 41760000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |